Coimbatore Retina Meet-December 10, 2025
Brief Summary
The Coimbatore Retina Meet (Dec 10, 2025, Hotel O’ by Tamara) brought together ophthalmologists and uveitis specialists to discuss retinal vasculitis and inflammatory retinal diseases, focusing on practical diagnosis and treatment strategies relevant to India.
Key Highlights
Keynote Lecture (Dr. Rupesh Agarwal, Singapore):
Covered classification, causes (infectious vs autoimmune), and pathophysiology of retinal vasculitis
Emphasized multimodal imaging (FA, OCT, OCTA) for accurate diagnosis
Discussed treatment protocols:
Antimicrobials for infections
Steroids & immunosuppressants for inflammation
Biologics for resistant cases
Highlighted importance of early diagnosis and long-term monitoring
Case-Based Learning Sessions
Six case presentations focused on real-world challenges:
IRVAN Syndrome: Rare condition with aneurysms and vasculitis; requires early laser + steroids
Frosted Branch Angiitis: Severe vascular inflammation linked to infections/autoimmune causes
Post-Fever Retinopathy: Diagnostic confusion after infections like dengue, COVID
Uveitic Macular Edema: Managing resistant cases using steroids, anti-VEGF & combination therapy
Refractory Uveitis Case: Importance of re-evaluating diagnosis (including lymphoma)
Ranibizumab Biosimilar: Effective, cost-friendly option for macular edema & neovascularization
Panel Discussion Insights
Strong focus on balancing cost vs advanced care in Indian settings
Importance of early aggressive treatment in severe cases
Growing role of:
Biologics (anti-TNF, IL-6)
Advanced imaging (OCTA)
Biosimilars for affordability
Key Takeaways
Accurate diagnosis requires systematic evaluation + imaging
Treatment must be cause-specific and stepwise
Refractory cases need rethinking diagnosis
Cost-effective options (biosimilars) are crucial in India
Collaboration improves outcomes in complex uveitis cases



